Latest Breaking News On - Stonepine capital management - Page 11 : vimarsana.com

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 5,440,000 shares, a decrease of 5.1% from the January 15th total of 5,730,000 shares. Approximately 10.9% of the shares of the stock are […]

Nova scotiaUnited statesRobertw bairdJamesm fratesPatrickd yeramianAmylyx pharmaceuticals company profileVanguard group incNews ratings for amylyx pharmaceuticals dailyAmylyx pharmaceuticalsStonepine capital managementGoldman sachs groupMarshall waceAmylyx pharmaceuticals incAmylyx pharmaceuticals stockBlackrock incDeutsche bank aktiengesellschaft